Topiramate: Difference between revisions
ClaireLewis (talk | contribs) |
Neil.m.young (talk | contribs) (Text replacement - "5 mg" to "5mg") |
||
Line 8: | Line 8: | ||
===Partial Seizures=== | ===Partial Seizures=== | ||
*monotherapy | *monotherapy | ||
**Dose: 200 mg PO bid; Start: | **Dose: 200 mg PO bid; Start: 25mg PO bid x1wk, increase by 50 mg/day qwk until 100 mg PO bid, then increase by 100 mg/day qwk; Info: doses >400 mg/day rarely more effective | ||
*adjunct therapy | *adjunct therapy | ||
**Dose: 100-200 mg PO bid; Start: | **Dose: 100-200 mg PO bid; Start: 25mg PO qd-bid x1wk, increase by 25-50 mg/day qwk; Info: doses >400 mg/day rarely more effective | ||
===seizures, primary generalized tonic clonic=== | ===seizures, primary generalized tonic clonic=== | ||
*monotherapy | *monotherapy | ||
**Dose: 200 mg PO bid; Start: | **Dose: 200 mg PO bid; Start: 25mg PO bid x1wk, increase by 50 mg/day qwk until 100 mg PO bid, then increase by 100 mg/day qwk; Info: doses >400 mg/day rarely more effective | ||
*adjunct therapy | *adjunct therapy | ||
**Dose: 200 mg PO bid; Start: | **Dose: 200 mg PO bid; Start: 25mg PO qd-bid x1wk, increase by 25-50 mg/day qwk; Info: doses >400 mg/day rarely more effective | ||
===Seizures, Lennox-Gastaut=== | ===Seizures, Lennox-Gastaut=== | ||
*adjunct therapy | *adjunct therapy | ||
**Dose: 100-200 mg PO bid; Start: | **Dose: 100-200 mg PO bid; Start: 25mg PO qd-bid x1wk, increase by 25-50 mg/day qwk; Info: doses >400 mg/day rarely more effective | ||
===Migraine headache, prophylaxis=== | ===Migraine headache, prophylaxis=== | ||
*50 mg PO bid | *50 mg PO bid | ||
**Start: | **Start: 25mg PO qhs x1wk, increase by 25mg/day qwk; Max: 200 mg/day | ||
==Pediatric Dosing== | ==Pediatric Dosing== |
Revision as of 04:17, 21 July 2016
Administration
- Type: anti epileptic
- Dosage Forms: 25,50,100,200 tabs; 15,25 caps
- Routes of Administration: PO
- Common Trade Names: Topamax
Adult Dosing
Partial Seizures
- monotherapy
- Dose: 200 mg PO bid; Start: 25mg PO bid x1wk, increase by 50 mg/day qwk until 100 mg PO bid, then increase by 100 mg/day qwk; Info: doses >400 mg/day rarely more effective
- adjunct therapy
- Dose: 100-200 mg PO bid; Start: 25mg PO qd-bid x1wk, increase by 25-50 mg/day qwk; Info: doses >400 mg/day rarely more effective
seizures, primary generalized tonic clonic
- monotherapy
- Dose: 200 mg PO bid; Start: 25mg PO bid x1wk, increase by 50 mg/day qwk until 100 mg PO bid, then increase by 100 mg/day qwk; Info: doses >400 mg/day rarely more effective
- adjunct therapy
- Dose: 200 mg PO bid; Start: 25mg PO qd-bid x1wk, increase by 25-50 mg/day qwk; Info: doses >400 mg/day rarely more effective
Seizures, Lennox-Gastaut
- adjunct therapy
- Dose: 100-200 mg PO bid; Start: 25mg PO qd-bid x1wk, increase by 25-50 mg/day qwk; Info: doses >400 mg/day rarely more effective
Migraine headache, prophylaxis
- 50 mg PO bid
- Start: 25mg PO qhs x1wk, increase by 25mg/day qwk; Max: 200 mg/day
Pediatric Dosing
Special Populations
Renal Dosing
- Adult: CrCl 10-70: decrease dose 50%; CrCl <10: decrease dose 75%; HD: give supplement
- Pediatric:
Hepatic Dosing
- Adult: not defined; caution advised
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion: